<p>We aim to use whole-genome medical sequencing (WGMS) to discover causative molecular lesions for a set of rare, severe phenotypes hypothesized to be caused by either somatic mutations, germline de nova heterozygous mutations, germline inherited recessive, or germline inherited dominant mutations in currently unknown or uncharacterized genes. The goal of this research is threefold: to identify causative sequence variants for disorders whose molecular etiology was previously unknown, to apply this insight to both the rare disorders under study and more common phenotypes, and to enhance the study of mutation on a genome-wide level.</p>

Biesecker Lab (NHGRI) Whole Genome Medical Sequencing for Gene Discovery

2 selected publications including "A Point Mutation in PDGFRB Causes Autosomal-Dominant Penttinen Syndrom..." (74 citations)

Biesecker Lab (NHGRI) Whole Genome Medical Sequencing for Gene Discovery

A Point Mutation in PDGFRB Causes Autosomal-Dominant Penttinen Syndrome.

Clinical management of patients with ASXL1 mutations and Bohring–Opitz syndrome, emphasizing the need for Wilms tumor surveillance